Cargando…
Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
Nanotechnology has opened up a world of possibilities for the treatment of brain disorders. Nanosystems can be designed to encapsulate, carry, and deliver a variety of therapeutic agents, including drugs and nucleic acids. Nanoparticles may also be formulated to contain photosensitizers or, on their...
Autores principales: | Habib, Saffiya, Singh, Moganavelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878382/ https://www.ncbi.nlm.nih.gov/pubmed/35215625 http://dx.doi.org/10.3390/polym14040712 |
Ejemplares similares
-
Poly-L-Lysine–Lactobionic Acid-Capped Selenium Nanoparticles for Liver-Targeted Gene Delivery
por: Naidoo, Shaigan, et al.
Publicado: (2022) -
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
por: Habib, Saffiya, et al.
Publicado: (2021) -
Dendrimers as Modifiers of Inorganic Nanoparticles for Therapeutic Delivery in Cancer
por: Zenze, Mkhuseli, et al.
Publicado: (2023) -
Anti-c-myc RNAi-Based Onconanotherapeutics
por: Habib, Saffiya, et al.
Publicado: (2020) -
A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles
por: Qiao, Lanxin, et al.
Publicado: (2020)